金融界8月18日消息，周一港股集体高开，盘面上，大型科技股多数走高，截至10：55，港股科技 50ETF(513980)涨1.40%，该基金年内至今已涨超46%！ 港股科技50ETF(513980)紧密跟踪中证港股通科技指数，成分股涵盖小米集团-W、阿里巴巴等一众港股 电子行业龙头，前十大权重股权重合计约66%。当前港股科技50ETF（513980）基金规模190亿，在跟 踪同指数ETF基金中规模第一。 看好港股科技股，不妨关注港股科技50ETF(513980)及其联接基金（A类：016495；C类：016496），助 力布局港股优质资产赛道。 风险提示：文中提及的指数成份股仅作展示，个股描述不作为任何形式的投资建议。任何在本文出现的 信息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，投资 人须对任何自主决定的投资行为负责。基金投资有风险，基金的过往业绩并不代表其未来表现，基金管 理人管理的其他基金的业绩并不构成基金业绩表现的保证，基金投资须谨慎。 本文源自：金融界 作者：E播报 热门个股方面，长城汽车涨超10%，中兴通讯涨超9%，京东健康、商汤-W、瑞声科技等涨超4%，信 ...

Group 1 - The core viewpoint of the articles highlights a positive trend in the Hong Kong stock market, particularly in technology and pharmaceutical sectors, with significant gains observed in the Hong Kong Technology 50 ETF and various individual stocks [1][2] - The Hong Kong Technology 50 ETF (513980) has seen a year-to-date increase of over 32%, with a recent trading volume of 5.07 billion yuan and a net inflow of 62.05 billion yuan since the beginning of the year [1] - Major stocks in the innovation drug sector have shown strong performance, with notable increases such as Genscript Biotech rising over 14% and 3SBio increasing over 7% [1] Group 2 - According to Huatai Securities, the recent positive signals from the US-China summit may reduce tariff friction, potentially enhancing China's growth expectations and providing upward momentum for the renminbi and its assets [1] - Industrial growth is anticipated to focus on technology, particularly the AI industry chain, with an emphasis on upstream computing power and downstream application innovation [2] - The Hong Kong Technology 50 ETF is the largest in its category, with a fund size of 135.99 billion yuan, reflecting the performance of leading companies in internet, new energy vehicles, and biomedicine sectors [2]

Group 1 - The Hong Kong stock market opened positively after the May holiday, with all three major indices rising, particularly the Hong Kong Technology 50 ETF (513980) which increased by 2.33% [1] - Notable individual stocks such as Meituan-W and Midea Group rose over 3%, while other companies like Weiyida and Great Wall Motors saw increases of over 2% and 1% respectively [1] - The Hong Kong dollar has been strengthening, nearing the 7.75 peg limit, prompting the Hong Kong Monetary Authority (HKMA) to intervene multiple times, indicating strong international capital demand for Hong Kong stocks [1] Group 2 - According to Cathay Securities, the net profit growth for Hong Kong stocks is expected to rebound in 2024, with a cumulative year-on-year increase of 9.8%, and significant growth anticipated in the second half of the year [1] - The first half of 2024 is projected to see a year-on-year growth of 7.5%, while the second half is expected to rise by 13.3%, reflecting a substantial increase in profitability [1] - The outlook for Hong Kong stocks remains positive due to resilient economic policies and a recovering technology cycle, suggesting sustained high profit growth [1] Group 3 - The Hong Kong Technology 50 ETF (513980) has a fund size of 14.4 billion yuan, making it the largest among ETFs tracking the same index [2] - This ETF closely follows the CSI Hong Kong Stock Connect Technology Index, which includes 50 leading technology companies with significant market capitalization and R&D investment [2] - The top ten constituent stocks account for over 70% of the ETF's weight, highlighting the concentration in major tech players [2]

Core Viewpoint - The Hong Kong stock market is gradually stabilizing and rebounding as the impact of tariffs diminishes, with significant gains in major indices, particularly in technology and consumer sectors [1][2]. Group 1: Market Performance - As of April 23, the Hang Seng Technology Index rose by 2.84%, the Hang Seng Index by 2.11%, and the Hang Seng China Enterprises Index by 1.83% [1]. - Since March 20, the Hong Kong stock market has experienced continuous adjustments, but has begun to recover due to interventions from state-owned enterprises [2]. Group 2: Investment Opportunities - The Hong Kong stock market is seeing a growing proportion of technology and new consumer companies, which are expected to account for 54.5% of the total market capitalization by the end of 2024 [2]. - ETFs focusing on technology, consumption, and innovative pharmaceuticals are becoming popular among investors, providing efficient access to these sectors [1][3]. Group 3: Specific ETF Products - The Hong Kong Technology 50 ETF (513980) targets large-cap technology leaders with high R&D investment and revenue growth, including companies like Meituan and Tencent [2]. - The Hang Seng Consumption ETF (513970) focuses on essential and discretionary consumer goods, excluding alcohol and internet platforms, aiming to capture opportunities in consumer recovery [3]. - The Hong Kong Innovative Drug 50 ETF (513780) tracks leading companies in the innovative pharmaceutical sector, which is relatively scarce compared to the A-share market [3].